首页> 外文期刊>Human Genetics >Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: evidence for association of ASCL1 with Parkinson's disease.
【24h】

Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: evidence for association of ASCL1 with Parkinson's disease.

机译:神经精神疾病中PHOX2B和ASCL1的遗传关联分析:ASCL1与帕金森氏病关联的证据。

获取原文
获取原文并翻译 | 示例
       

摘要

We previously identified frequent deletion/insertion polymorphisms in the 20-alanine homopolymer stretch of PHOX2B (PMX2B), the gene for a transcription factor that plays important roles in the development of oculomotor nerves and catecholaminergic neurons and regulates the expression of both tyrosine hydroxylase and dopamine beta-hydroxylase genes. An association was detected between gene polymorphisms and overall schizophrenia, and more specifically, schizophrenia with ocular misalignment. These prior results implied the existence of other schizophrenia susceptibility genes that interact with PHOX2B to increase risk of the combined phenotype. ASCL1 was considered as a candidate interacting partner of PHOX2B, as ASCL1 is a transcription factor that co-regulates catecholamine-synthesizing enzymes with PHOX2B. The genetic contributions of PHOX2B and ASCL1 were examined separately, along with epistatic interactions with broader candidate phenotypes. These phenotypes included not only schizophrenia, but also bipolar affective disorder and Parkinson's disease (PD), each of which involve catecholaminergic function. The current case-control analyses detected nominal associations between polyglutamine length variations in ASCL1 and PD (P=0.018), but supported neither the previously observed weak association between PHOX2B and general schizophrenia, nor other gene-disease correlations. Logistic regression analysis revealed the effect of ASCL1 dominant x PHOX2B additive (P=0.008) as an epistatic gene-gene interaction increasing risk of PD. ASCL1 controls development of the locus coeruleus (LC), and accumulating evidence suggests that the LC confers protective effects against the dopaminergic neurodegeneration inherent in PD. The present genetic data may thus suggest that polyglutamine length polymorphisms in ASCL1 could influence predispositions to PD through the fine-tuning of LC integrity.
机译:我们之前在PHOX2B(PMX2B)的20-丙氨酸均聚物序列中发现了频繁的缺失/插入多态性,该基因是转录因子的基因,在动眼神经和儿茶酚胺能神经元的发育中起着重要作用,并调节酪氨酸羟化酶和多巴胺的表达β-羟化酶基因。检测到基因多态性与整体精神分裂症之间存在关联,更具体地说,与眼部错位的精神分裂症相关。这些先前的结果暗示存在与PHOX2B相互作用以增加合并表型风险的其他精神分裂症易感基因。 ASCL1被认为是PHOX2B的候选相互作用伴侣,因为ASCL1是与PHOX2B共同调节儿茶酚胺合成酶的转录因子。分别检查了PHOX2B和ASCL1的遗传贡献,以及与更广泛的候选表型的上位相互作用。这些表型不仅包括精神分裂症,还包括双相情感障碍和帕金森氏病(PD),它们均涉及儿茶酚胺能功能。当前的病例对照分析检测到了ASCL1和PD中的聚谷氨酰胺长度变化之间的名义关联(P = 0.018),但既不支持先前观察到的PHOX2B与一般精神分裂症之间的弱关联,也不支持其他基因疾病关联。 Logistic回归分析显示ASCL1显性x PHOX2B添加剂的影响(P = 0.008)作为上位基因-基因相互作用增加PD风险的影响。 ASCL1控制着蓝斑轨迹(LC)的发育,并且越来越多的证据表明,该LC对PD中固有的多巴胺能神经变性具有保护作用。因此,目前的遗传数据可能表明,ASCL1中的聚谷氨酰胺长度多态性可能通过LC完整性的微调而影响PD的易感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号